PDIA3P1 and central nervous system cancer: Further analysis using The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA) database showed that high PDIA3P1 expression represents a more malignant tumor type and results in poorer outcomes in glioma patients.